KLRS Stock Analysis: Buy, Sell, or Hold?
KLRS - Kalaris Therapeutics, Inc. Common Stock
$4.35
0.01 (0.35%)
▲
5d:
+4.2%
30d:
-16.76%
90d:
-50.68%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When KLRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: KLRS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: KLRS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: KLRS is currently trading at $4.34, which is considered oversold relative to its 30-day fair value range of $4.42 to $5.12.
Technical Outlook: Technically, KLRS is in a strong downtrend. Immediate support is located at $4.02, while resistance sits at $5.60.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.75 (+333.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, KLRS is in a strong downtrend. Immediate support is located at $4.02, while resistance sits at $5.60.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.75 (+333.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.42 -
$5.12
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 333.0% below Wall St target ($18.75)
Trading Range Analysis
30-Day Trading Range
$4.42 -
$5.12
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.02
Resistance Level
$5.60
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.74
Wall Street Target
$18.75
(+333.0%)
Share & Embed Analysis
Last updated: June 15, 2026 2:54 PM ET
Data refreshes hourly during market hours. Next update: 3:54 PM
Data refreshes hourly during market hours. Next update: 3:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KLRS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Brett R Hagen
SELL
1915 shares
2026-03-20
Srinivas Akkaraju
BUY
479847 shares
2025-12-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 64 BUY |
